MAA
ASPX

Managed Account Advisors’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Managed Account Advisors’s Portfolio ASPX Stock Details ASPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-63
Closed -$6K – 3214
2015
Q1 		$6K Sell
63
-109
-63% -$7.26K ﹤0.01% 2873
2014
Q4 		$9K Sell
172
-84
-33% -$2.47K ﹤0.01% 2637
2014
Q3 		$7K Buy
256
+33
+15% +$702 ﹤0.01% 2619
2014
Q2 		$5K Hold
223
– – ﹤0.01% 2611
2014
Q1 		$7K Buy
+223
New +$5.99K ﹤0.01% 2565

Managed Account Advisors's ASPX Position: Q2 2015 in Review

Managed Account Advisors sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 63 shares — an estimated $6K sold.

Managed Account Advisors first reported a position in ASPX in Q1 2014 and held it in 5 quarters. The position peaked at $9K in Q4 2014. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • Managed Account Advisors reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Managed Account Advisors sold 63 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $6K.
  • Managed Account Advisors first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2014 and held it in 5 quarters.
  • Managed Account Advisors's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $9K in Q4 2014.
  • 0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.